This study reports a high prevalence of ESBL-PE associated with strong resistance to quinolones and cotrimoxazole (over 80%), which calls for increased surveillance of these superbugs, the adoption of ...

This study reports a high prevalence of ESBL-PE associated with strong resistance to quinolones and cotrimoxazole (over 80%), which calls for increased surveillance of these superbugs, the adoption of ...

We aimed to evaluate the prevalence of plasmid-mediated-quinolone-resistance (PMQR) and extended-spectrum beta-lactamase- (ESBL) producing gram-negative organisms among primigravid women with ...

ESBL-producing E coli is considered a growing public health threat because the ESBL enzyme confers resistance to multiple classes of antibiotics and makes common infections like UTIs difficult to ...

No distinction between acquired AmpC and natural AmpC was made. These isolates may also harbour other resistance mechanisms (e.g., ESBL-encoding genes). “Presumptive ESBL + AmpC producers” refers to ...

Resistance to cefuroxime (first line for SBP treatment in our ... Notably, there were no cases of ESBL, MRSA or VRE. 21% of patients were on prophylactic antibiotics at time of SBP. Median length of ...

Recently, antibacterial drugs against ESBL-producing Gram-negative bacteria accounted for ∼15% (2 out of 13) of all antibacterial drugs undergoing development in Phase II trials or later ...

Zoonotic Antimicrobial Resistance - Annamari Heikinheimo Group's research focuses ... routes of zoonotic antimicrobial resistant bacteria along the food chain, such as ...

Background: Infections caused by extended-spectrum β-lactamase (ESBL)–producing gram-negative organisms are a growing concern in hospitalized patients. Traditionally, these infections can be ...